EXAGEN INC. (XGN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
XGN currently has 24.1M outstanding shares. with limited dilution risk as only 2.38M additional shares (9.9%) are authorized for issuance. The company has significantly diluted shareholders by 29.64% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 10, 2026 |
10-K filing | 24.1M shares outstanding |
24M | 2.4M |
| Nov 04, 2025 |
10-Q filing | 22.9M shares outstanding |
23M | 3.5M |
| Jul 29, 2025 |
10-Q filing | 21.1M shares outstanding |
21M | 5.3M |
| Jun 20, 2025 |
S-3 filing: An S-3 filing was submitted on 2025-06-20 for shares of common stock issuable upon the vesting and exercise of a warrant certificate. |
19M | 7.9M |
| May 05, 2025 |
10-Q filing | 18.6M shares outstanding |
19M | 6.7M |
| Mar 11, 2025 |
10-K filing | 18.2M shares outstanding |
18M | 7.1M |
| Nov 12, 2024 |
10-Q filing | 18.3M shares outstanding |
18M | 7M |
| Aug 05, 2024 |
10-Q filing | 18.2M shares outstanding |
18M | 7.1M |
| May 13, 2024 |
10-Q filing | 17.9M shares outstanding |
18M | 7.3M |
| Mar 18, 2024 |
10-K filing | 17.7M shares outstanding |
18M | 7.6M |
| Nov 27, 2023 |
S-3/A filing: This S-3/A filing relates to an at-the-market offering of common stock with an aggregate offering price of up to $10,223,534, with the company planning to use the net proceeds for general corporate purposes. |
17M | 8.3M |
| Nov 17, 2023 |
S-3 filing: The offering is for common stock with an aggregate offering price of up to $10,822,402. The offering is an "at the market offering" that may be made from time to time through our sales agent, TD Cowen. |
17M | 8.5M |
| Nov 13, 2023 |
10-Q filing | 17.7M shares outstanding |
18M | 990K |
| Aug 07, 2023 |
10-Q filing | 17.7M shares outstanding |
18M | 1M |
| May 15, 2023 |
10-Q filing | 17.5M shares outstanding |
18M | 1.2M |
| Mar 20, 2023 |
10-K filing | 17.1M shares outstanding |
17M | 1.6M |
| Nov 21, 2022 |
10-Q filing | 17.1M shares outstanding |
17M | 1.6M |
| Aug 04, 2022 |
10-Q filing | 17.1M shares outstanding |
17M | 1.6M |
| May 11, 2022 |
10-Q filing | 17.0M shares outstanding |
17M | 1.7M |
| Mar 22, 2022 |
10-K filing | 16.0M shares outstanding |
16M | 2.7M |
| Nov 10, 2021 |
10-Q filing | 16.9M shares outstanding |
17M | 1.7M |
| Aug 09, 2021 |
10-Q filing | 16.9M shares outstanding |
17M | 1.8M |
| May 11, 2021 |
10-Q filing | 16.9M shares outstanding |
17M | 1.8M |
| Mar 16, 2021 |
10-K filing | 12.7M shares outstanding |
13M | 6M |
| Nov 10, 2020 |
S-3 filing: The filing is an S-3 registration statement containing two prospectuses: a base prospectus for the offering, issuance and sale of up to $150 million in securities, and a secondary offering prospectus for the offer and sale of common stock by selling stockholders. |
5.8M | 13M |
| Nov 10, 2020 |
10-Q filing | 12.7M shares outstanding |
13M | 6M |
| Jul 28, 2020 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| May 11, 2020 |
10-Q filing | 12.6M shares outstanding |
13M | 0 |
| Mar 25, 2020 |
10-K filing | 12.6M shares outstanding |
13M | 0 |